Literature DB >> 66569

Effect of granulocytic chalone on acute myeloid leukaemia in man. A follow-up study.

J A Vilpo, A Levanto, W A Jones.   

Abstract

Non-pyrogenic preparations of granulocytic chalone have been administered to patient with acute myeloid leukaemia (A.M.L.) who had relapsed after chalone-induced complete remission of the disease. Another regression of the leukaemia was obtained. Normal and leukaemic granulocytes were inhibited without effect on other cell types. Survival was prolonged in 4 other patients with A.M.L. Further investigations are needed to elucidate the therapeutic role of granulocytic chalone.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 66569

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  6 in total

1.  Identification of an exceptionally short open reading frame in the genome of man, encoding a decapeptide, which regulates granulopoiesis by negative feedback.

Authors:  T Rytömaa
Journal:  Cell Prolif       Date:  2014-05-29       Impact factor: 6.831

2.  Membrane associated events during proliferative inhibition of granulocyte precursors.

Authors:  H B Benestad; R Heikkilä
Journal:  Blut       Date:  1986-11

Review 3.  [Humoral factors in the regulation of cell proliferation in haematopoiesis. I. Granulopoiesis and lymphopoiesis (author's transl)].

Authors:  E Heidemann
Journal:  Klin Wochenschr       Date:  1980-10-15

4.  Spontaneous death of rat chloroleukaemia cells induced by an endogenous growth inhibitor.

Authors:  T Rytömaa; K Grip-Rytömaa
Journal:  Cell Prolif       Date:  2017-12-10       Impact factor: 6.831

5.  Granulopoiesis inhibition in acute inflammation: comparative studies in healthy and leukaemic mice.

Authors:  M Hamood; F Corazza; P F Bluche; H El Teraifi; P Fondu
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

6.  Cachexia: a 'last ditch' mechanism of host defence?

Authors:  M J Murray; A B Murray
Journal:  J R Coll Physicians Lond       Date:  1980-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.